Albany, New York, August 17, 2016: Market Research Reports Search Engine (MRRSE) has announced that its repository now features a report titled “Cytology and HPV Testing Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024.” The report, by Transparency Market Research (TMR), states that the cytology and HPV testing market stood at US$7.9 bn in 2015 and is poised to reach US$10.5 bn by 2024, expanding at a 2.90% CAGR from 2016 to 2024.
The report begins by presenting an introduction to the global cytology and HPV testing market. This section encapsulates the prime drivers, opportunities, trends, and challenges in the market. The market attractiveness evaluation and Porter’s five forces analysis also fall under this section of the study. As per the report, the increasing awareness among the global population has resulted in more people undergoing high-accuracy diagnostic tests, thus fuelling the growth of the overall cytology and HPV testing market.
Furthermore, the increasing occurrence of HPV infections as well as cervical cancer globally will augment the development of the market for cytology and HPV testing. The soaring number of programs encouraging cervical cancer screening will also contribute toward the growth of this market. Contrariwise, the absence of suitable primary healthcare infrastructure in developing nations may negatively impact the development of this market.
In the following section of the study, the market’s segmentation has been presented. In terms of product and service, the report classifies the market into HPV testing and cytology testing. Within cytology testing, the sub-segments of systems, services, and assay kits have been presented. Of these, cytology testing services constituted the largest share of 78.70% in the cytology testing market in 2015. Similarly, under HPV testing, subcategories such as services, assay kits, and systems have been studied. Amongst these, HPV testing services represented a significant share of 78.2% in the HPV testing market in 2015.
In terms of geography, the report categorizes the market for cytology and HPV testing into North America, Asia Pacific, Europe, and Rest of the World (RoW). Of these, North America constituted the largest share of 52.5% in the market in 2015 owing to the increasing availability of cutting-edge diagnostic test kits and the growing occurrence of cervical cancers and HPV infections in this region. On the other hand, the Asia Pacific cytology and HPV testing market is also predicted to witness rapid growth owing to it being amongst the most lucrative destinations for cytology and HPV testing.
As per the report, the prominent players in the market are Becton, Dickinson and Company, Abbott Laboratories, Inc., Fujirebio Diagnostics, Inc., Hologic, Inc., and OncoHealth Corporation, among others.
Browse Full Global Cytology and HPV Testing Market Report with TOC:http://www.mrrse.com/cytology-hpv-testing-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207